Back to STATE STREET CORP STATE STREET CORP

RXRXRXRX
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in RECURSION PHARMACEUTICALS IN

STATE STREET CORP holds 34.7M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $127.4M as of 2026-Q2. The position was increased (+21.8% shares). RXRX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$127.4M

Current Shares

34.7M

Total Value Change

+$7.6M

Total Shares Change

+22.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
34.7M
+21.8%
$127.4M0.0%$3.67
36
2026-Q1
Increased
28.5M
+12.5%
$87.5M0.0%$3.54
34
2025-Q4
Increased
25.3M
+38.7%
$103.6M0.0%$4.11
39
2025-Q3
Increased
18.3M
+63.4%
$89.2M0.0%$4.91
43
2025-Q2
Decreased
11.2M
-14.6%
$56.6M0.0%$5.03
0
2025-Q1
Increased
13.1M
+4.0%
$69.2M0.0%$5.81
31
2024-Q4
Decreased
12.6M
-2.3%
$85M0.0%$6.77
0
2024-Q3
Increased
12.9M
+47.1%
$84.8M0.0%$6.98
41
2024-Q2
Decreased
8.7M
-15.5%
$65.6M0.0%$7.50
0
2024-Q1
Decreased
10.4M
-14.8%
$103.2M0.0%$9.97
0
2023-Q4
New
12.2M
-
$119.8M0.0%$9.86
42

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used